Close Menu

Chris Hibberd

Chris Hibberd has joined the board of directors of Oxford Genome Sciences. Hibberd is currently CEO of Astute Medical and is a former senior vice president of corporate development for Biosite. Prior to joining Biosite, he was a manager at the Boston Consulting Group.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.

The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.

Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.